CD4(+) T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.
CD4(+) T 细胞介导 BCMA CAR-T 细胞治疗后 CAR-T 细胞相关的免疫相关不良事件。
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04121-8
Ho Matthew, Paruzzo Luca, Noll Julia Han, Stella Federico, Devi Pooja, Ndeupen Sonia, Day Yael A, Chen Gregory M, Cohen Ivan J, Ramirez-Fernandez Angel, Waxman Adam, Kapur Shivani, Chen Fang, Xu Rong, Huff Andrew, Jarocha Danuta, Patel Vrutti, Bochi-Layec Audrey C, Ramasubramanian Ranjani, Liu Shan, Bouvier Riemke, de Souza Vitor B, Patel Heta, Li Ziyu, Carturan Alberto, Michener Peter, Hopkins Caitlin R, Koucky Owen, Minehart Janna, Dimitri Alex, Nabar Neel R, Hasanali Zainul S, Ciccarelli Bryan T, Hung Putzer, Williams Erik, Bartoszek Robert, Lavorando Maya, Mohan Suyash, Gonzalez Vanessa E, Porazzi Patrizia, Bhoj Vijay G, Apostolidis Sokratis A, Vogl Dan T, Porter David L, Scholler John, Diorio Caroline, Roche Aoife M, Everett John K, Bushman Frederic D, Nathanson Katherine L, Stadtmauer Edward A, Susanibar-Adaniya Sandra P, Garfall Alfred L, Ruella Marco, Cohen Adam D, Fraietta Joseph A
